Magda L. Altinok

Odense C, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome.

Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Published: April 17, 2018

Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS.

Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS.

Journal: Endocrine connections

Published: February 16, 2018

Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.

Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.

Journal: Human reproduction (Oxford, England)

Published: December 14, 2015

Total testosterone levels are often more than three times elevated in patients with androgen-secreting tumours.

Total testosterone levels are often more than three times elevated in patients with androgen-secreting tumours.

Journal: BMJ case reports

Published: January 25, 2015

Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.

Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.

Journal: Metabolism: clinical and experimental

Published: January 21, 2015

Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.

Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.

Journal: Human reproduction (Oxford, England)

Published: June 07, 2014

Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome.

Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome.

Journal: Journal of endocrinological investigation

Published: April 25, 2014

Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome.

Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome.

Journal: The Journal of clinical endocrinology and metabolism

Published: April 19, 2014

Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population-based cohort study.

Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population-based cohort study.

Journal: Clinical endocrinology

Published: July 29, 2013

Association of polycystic ovary syndrome susceptibility single nucleotide polymorphism rs2479106 and PCOS in Caucasian patients with PCOS or hirsutism as referral diagnosis.

Association of polycystic ovary syndrome susceptibility single nucleotide polymorphism rs2479106 and PCOS in Caucasian patients with PCOS or hirsutism as referral diagnosis.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: January 04, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026